Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 475

Results For "IND"

6575 News Found

Proexp Pharma collaborates with Carbanio
News | June 02, 2022

Proexp Pharma collaborates with Carbanio

As per partnership, Carbanio will arrange raw materials and other custom chemicals for Proexp Pharma Pvt. Ltd. through an uninterrupted digital process of the company


BGS Gleneagles launches its refurbished advanced emergency & trauma center
Healthcare | June 02, 2022

BGS Gleneagles launches its refurbished advanced emergency & trauma center

120+ members of multi-disciplinary medical team are trained to provide seamless, outcome driven trauma and emergency care


PMBI first time ever crossed Rs. 100 crore sales in May, 2022
Policy | June 02, 2022

PMBI first time ever crossed Rs. 100 crore sales in May, 2022

Govt. has set a target to increase the number of JanAushadhi Kendras to 10,000 by March 2024


Govt. launches 2-months long ‘Har Ghar Dastak 2.0’ campaign to expedite Covid-19 vaccination coverage
Policy | June 02, 2022

Govt. launches 2-months long ‘Har Ghar Dastak 2.0’ campaign to expedite Covid-19 vaccination coverage

Focussed campaigns for old age homes, schools/colleges, prisons, brick kilns to be taken up by States/UTs


Cipla adds capacity of captive renewable energy power plant in Maharashtra & Karnataka
News | June 02, 2022

Cipla adds capacity of captive renewable energy power plant in Maharashtra & Karnataka

By 2025, Cipla plans to achieve carbon and water neutrality, zero-waste to landfill, anti-microbial resistance stewardship and green chemistry.


USFDA accepts dupilumab for priority review in adults with prurigo nodularis
Drug Approval | June 01, 2022

USFDA accepts dupilumab for priority review in adults with prurigo nodularis

Dupixent would be the first and only medicine specifically indicated to treat prurigo nodularis in the U.S., if approved


ENTOD Pharmaceuticals gets DCGI nod to carry out the phase 3 trials of 0.05% atropine eye drops
Drug Approval | June 01, 2022

ENTOD Pharmaceuticals gets DCGI nod to carry out the phase 3 trials of 0.05% atropine eye drops

Low-dose atropine has emerged as an effective approach to slow the progression of myopia in children


Ayu Health Hospitals announces t expansion plan in Rajasthan
Healthcare | June 01, 2022

Ayu Health Hospitals announces t expansion plan in Rajasthan

This expansion announcement came right after raising series B funding of $27 Mn in a round led by Fundamentum Partnership, earlier this month.


FDA approves Roche’s Evrysdi for use in babies under two months with SMA
Drug Approval | June 01, 2022

FDA approves Roche’s Evrysdi for use in babies under two months with SMA

Evrysdi has proven efficacy in babies, children and adults with more than 5,000 patients treated to date


Tetra Bio-Pharma appoints CFO
People | June 01, 2022

Tetra Bio-Pharma appoints CFO

Auld is a seasoned Financial Executive with over 30 years of relevant experience